Yasin Keshvargar
  1. Partner

Mr. Keshvargar is a partner in Davis Polk’s Corporate Department in New York, practicing in the Capital Markets Group. He advises domestic and foreign issuers and underwriters on a broad range of transactions, including initial public offerings and other equity offerings, public and private high-yield, investment-grade and convertible debt financings, restructurings and cross-border transactions. He also advises clients ranging from early-stage privately held companies to well-known seasoned issuers on governance, SEC reporting, strategic transactions and other corporate law matters. His practice ranges across a variety of industries, including biotech, consumer and retail, fintech, technology and life sciences and healthcare.

Work Highlights

Mr. Keshvargar’s recent experience includes the following transactions:

IPOs
  • Initial public offerings by foreign private issuer emerging growth companies including Ablynx (Belgium), Advanced Accelerator Applications (France), Avolon (Ireland), BioNTech (Germany) GeoPark (Argentina) and Innate Pharma (France)
  • Initial public offerings by US emerging growth companies, including Cvent, Evolent Health, Jounce Therapeutics, Magenta Therapeutics, Ophthotech, Progyny, Solid Biosciences and Stoke Therapeutics
  • Initial public offerings by non-emerging growth companies, including Grupo Aval, the largest U.S. IPO by a Latin American issuer in 2014, and Hudson News
Other Equity Offerings
  • Numerous representations of issuers and placement agents in connection with pre-IPO private placements and cross over rounds, PIPEs, forward sale transactions and ATM programs
  • Follow-on or secondary offerings by Advanced Accelerator Applications, Cvent, Energizer Holdings, Evolent Health, Hilton, PTC Therapeutics and Southwestern Energy
Investment- and High-Grade Debt
  • Offerings by Bombardier, Heineken, Mylan, Evolent Health and PTC Therapeutics
High-Yield Debt
  • High-yield debt offerings by Chobani, Western Refining, NCI Building Systems, Murphy Oil and XPO Logistics
Convertible Debt
  • Convertible debt offerings by Evolent Health, Southwestern Energy and PTC Therapeutics

Recognition

  • Chambers Latin America “Associate to Watch” – Capital Markets, 2013 and 2014

Professional History

  • Partner since 2019
  • Counsel, 2017-2019
  • Davis Polk since 2008

Bar Admissions

  • State of New York

Education

  • LL.B., King's College London, 2006
    • Clifford Chance Prize for Outstanding Performance
    • First Class Honours
  • Maîtrise, Université Panthéon-Sorbonne - Paris 1, 2006
  • LL.M., Harvard Law School, 2008

Languages

  • Arabic
  • French